PULSE IMAGING, Inc. Company Overview 11/12/08 A World Without Skin Biopsies NON-INVASIVE EARLY SKIN CANCER DIAGNOSTIC SYSTEM.

Slides:



Advertisements
Similar presentations
Overview of the Keys to Successful Commercialization Gerald J. Siuta, Ph.D. President Siuta Consulting, Inc. Tucson, Arizona October 18, 2001.
Advertisements

Detecting Breast Cancer using Thermal and Optical Data AngelaBenFunkeMarkNancy.
Confidential The Device Development Industry December 4, 2010 North American Neuromodulation Society 14 th Annual Meeting Frank Fischer President and CEO.
DeLegge Medical Tech Accelerator Dr Mark and Rebecca DeLegge.
Disruptive Healthcare Innovation Initiative
ABC Company John Entrepreneur President and CEO. 2 Company Overview Provide descriptive but succinct statement about your business.
Practice-changing technology to get depression patients into remission faster.
Boston University Slideshow Title Goes Here 1 The SmartSleepSock Value Proposition A wearable, low-profile, low-cost device for preventing falls. Description.
International Society of Orthopedic Centers Mayo Clinic Overview April 29 – May 1, 2010.
16 November 2004Biomedical Imaging BMEN Biomedical Imaging of the Future Alvin T. Yeh Department of Biomedical Engineering Texas A&M University.
SENO MEDICAL INSTRUMENTS OPTO-ACOUSTIC SYSTEMS FOR MEDICAL IMAGING AND TOMOGRAPHY Alexander A. Oraevsky, Ph.D. Chief Scientific Officer, Seno Medical Instruments.
Bretley Hanson Caroline Leibinger Jered Wikander Photonic Funnel Project.
Karen LeVert, CEO Southeast TechInventures (STI) Research Triangle Park, NC x100 University.
Students to Start-ups Entrepreneurial Skills Workshop Series The Les Kilpatrick.

SUCCESS FACTORS IN THE PHARMACEUTICAL MARKETPLACE
Board of Directors Meeting February 2014 Scott Marland, PhD BioInnovations Gateway Executive Director Some thoughts on Product Development.
Commercialization of University Technology Innovation, Technology Transfer and Licensing Jack Turner, Associate Director M.I.T. Technology Licensing Office.
Proprietary and Confidential © ORIGINATE VENTURES 2010 Business Plan.
The Alfred E. Mann Institute for Biomedical Engineering An Experiment in Technology Transfer Gerald E. Loeb, M.D. Director of the Medical Device Development.
International Market Partner PITCHING TEMPLATE.
BIOME ™ : Bio Innovations and Opportunities in Medicine and Engineering Robert G. Radwin, Professor & Chair, Biomedical Engineering Lawrence A. Casper,
Malignext Targeting Technologies TARGETING A CURE THROUGH INNOVATION.
 Dave Alburty, CEO, InnovaPrep, LLC  Maria Meyers, Executive Director, KCSourceLink  Dr. Gary Clapp, President & CEO, Institute for Industrial and.
New Attitude is the developer, manufacturer and marketer of innovative lifelike mass market customized external breast prostheses using 3D imaging and.
Taking an Idea and getting it to the Market ConceptDevelopmentFeasibilityImplementation Market Milestones Concept Definition Overall Plan Final Product/Service.
UCLA Nanoscale Measurement System March 18, 2005 Nanoscale Measurement System Non-confidential summary of UCLA technology available for licensing, Case.
LLNL-PRES This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under contract.
Kunal Mitra Professor, Mechanical and Aerospace Engineering Department Director- Biomedical Engineering Program Florida Institute of Technology, Melbourne,
1 Value Assessment of Development-Stage Assets Pharmaceutical Products, Medical Devices, and Related Intellectual Property Frank S. Castellana, M.D., Eng.Sc.D.
IGEM Project Technology Name Presenter’s Information and Title Title of Industry Contacts and University Contacts.
Partnering with Federal Labs: A Panel Discussion FLC Mid-Atlantic Region Annual Meeting October 24, 2007.
PIPER JAFFRAY COMPANIES APRIL 13, CAUTION REGARDING FORWARD-LOOKING STATEMENTS Statements contained in this presentation that are not historical.
1. 2 Who We Are – North Texas RCIC Connecting Innovation & Capital Our mission... to accelerate the growth of the North Texas technology based economy.
2008 Patent Score Card: How UCF is helping accelerate Florida’s knowledge-based economy MJ Soileau Vice President for Research and Commercialization.
Global Recognition of the Indian Biotech Sector - The Road Ahead Sept 26,2003 Hyderabad.
1 Company Name (Presenter’s name) Phone # Tag line.
HealthStart India Mr. Pradeep K. Jaisingh Chairman & Founder Enabling Healthcare Entrepreneurship.
1 Bi o medical Designs Provides Smart Catheter Solutions January 2012.
DebrideX Surgical Strategy & Business Plan. Our Team Grygorii Yefremov - CEO Ranjan Upadhyay - CFO Prasant Varghese - CMO Krishn Khanna - CRO Srinivas.
HistoIndex Pte.Ltd. property. All Rights Reserved Confidential “Future of Biomedicine” Industry Day University of Glasgow 24 th Sept 2015.
Diagnostic Imaging Center of Macomb Business Plan.
Project Clot: Clot Detection Device for Stroke Prevention Team Atriumph: Erica Kim, Angela Li, Sam Vallagomesa, Michael Williams-Hart.
1/5/2008MPDNCenter Value Proposal 1 MarkPap LLC: Value proposal for Investors Overview of the Global MPD Networking Center December 30, 2008.
1.  Mission statement  Stage of development  Business plan status  Legal entity status  Location  Number of employees 2 New World Angels.
Financial Review Bell Manufacturing H. Bell March 24, 2002.
Medical Robotics UH MRI-guided Robotic Interventions and Surgeries This technology was supported by the NSF award CNS entitled “Multimodal.
[Business/Concept Name] [Presenter, Key Personnel] ***Remember as you draft your slides that there is a hard 12 minute stop on your presentation***
 Teva Pharmaceuticals Garrett Hoffman. Agenda  Company Overview  Drivers and Trends  Valuation  Recommendation  WOOF Discusion.
1 Promotion in Management and Research Tracks in Industry Magdalena Alonso-Galicia, PhD Cardiovascular Diseases Department Merck Research Laboratories.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Automated Breast Ultrasound System Industry Analysis by Product, Application, Region, 2024.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
COV Q report presentation
Startup project presentation deck
Translational Research: Case of Istanbul University
Company Name Mission statement Stage of development
Company Name Mission statement Stage of development
Your Name, Founder, CEO Address Cell phone
Business Case Development Key Components :
Amy Johnson Director & Entrepreneur-in-Residence.
Introduction to Biosensors
Fibrogen – Prophix story
Investment Opportunity and
Teledyne DALSA – Prophix story
Biomedical Business Model Canvas
Enabling Rapid and Accurate Cancer Diagnosis
Small Animal Imaging Market Global Industry Analysis, Size & Growth
Proposal Presentation to the
Company Name Mission statement Stage of development
Presentation transcript:

PULSE IMAGING, Inc. Company Overview 11/12/08 A World Without Skin Biopsies NON-INVASIVE EARLY SKIN CANCER DIAGNOSTIC SYSTEM

Problem n What if there is a skin cancer diagnostic technique that is painless, more accurate, less expensive, and quick? –Early cancer detection critical –Current testing can be time-consuming, expensive, and uncomfortable –Currently dermatologists do multiple biopsies to detect a single case of melanoma –Lack of accurate instruments

Background n Short Pulse Laser Based Optical Tomography System –world’s first fully software-controlled, desktop- size –ultra-short pulse laser system providing high spatial and temporal resolution –displays soft tissue contrast at cellular level n Preliminary proof of concept demonstrated in animal model n Provisional Patent (April 2006); Full patent filed (March 2007)

Solution n Non-invasive Real-time Cancer Diagnostics –Less expensive –Eliminate unnecessary costly biopsies –Comfortable –Transportable compared to other imaging techniques –High sensitivity, specificity, and resolution –Fast image turnaround for patients –Reduce the probability of missing lesions especially in the margins compared to biopsies

Resources and Capabilities n Leverages existing Florida Tech’s human capital and infrastructure n Development partnership with Raydiance Inc. n Intellectual Property and Business Transactional capabilities through FIT Tech Transfer Office n Design and prototyping capabilities Developer PlatformProduction VersionConcept Platform Volume Production

Paradigm Shifts n Discovery at university n Preliminary technology development completed n Design factors leading to several generation systems n Clinical trials for next generation system n Regulatory approval from FDA n Manufacture and ship systems to customers

Market and Competition n Market size and Growth rate –More than 10 million skin biopsies are performed annually in US- by far the most common biopsy –More than 10 million skin biopsies are performed annually in US - by far the most common biopsy –Medical imaging market worth about $15B in 2006; app. 50% of the revenues garnered by the core modalities MRI, CT, x-ray, ultrasound –App. double digit market growth over the next five years –Medical expenditure for melanoma is $2.5B n Competitive Technologies –Biopsy vs Imaging Diagnostics –Biopsy vs Imaging Diagnostics such as MRI –Optical Coherence Tomography (OCT)

Optical Tomography BiopsyMRICTPET time15 mins4-14 days mins mins cost$$$$$$$$$$$ safetyExcellentPoorGoodPoorFair resolu tion Very GoodGoodVery Good Good sizeExcellentGoodPoorFair Competition

Sales and Distribution Target Distribution Partners or Customers Shands Healthcare Orlando Regional Healthcare Kaiser Permanente Mayo Clinic Sloan Kettering Research Institutes Research Hospital Radiologists PULSE IMAGING sales in year systems $300,000 per unit 40% per year growth

Management Team n CEO - TBA n Dr. Kunal Mitra - CTO; Responsible for overall product design and development n Robert Merrill - Florida Tech Tech Transfer Office n n Ari Schuler - Raydiance Inc. (A DFJ Company); Commercialization partner n n Dr. Carolyn Fausnaugh - Florida Tech School of Business; Responsible for market research n n Dr. Grace – Florida Tech Biology Department; Responsible for animal studies n n Regulatory Consultant - TBA

Financial Forecast Revenue $ 1.75 million $ 8.5 million $16.5million$32million $60 million Margin-$500k $ million $6.5 million $ 13 million $24 million Profit-$50k$287k$975k $2.6 million $6 million Headcount

Use of Proceeds n Funding –Initial investment - $1 million –First year (2009) n Uses: –Prototype development for animal studies –Regulatory data development cost –Completion of clinical trials through partnership –Working investment capital

Summary n “A World Without Skin Biopsies” n Conducting animal studies for safety and efficacy n Product development partnership in place n Patent application filed (2007) n Need for initial investment of $1 million Kunal Mitra, Ph.D. Professor Mechanical and Aerospace Engineering Department Director- Biomedical Engineering Program Florida Institute of Technology Phone: (321)